Back to Journals » OncoTargets and Therapy » Volume 9

Case report

Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor

       
Total article views   HTML views PDF downloads Totals
8,116 Dovepress* 7,446+ 1,381 8,827
PubMed Central* 670 257 927
Totals 8,116 1,638 9,754
*Since 8 January 2016
+Since July 2016

View citations on PubMed and Google Scholar